Oxford BioMedica plc Stock London S.E.
Equities
GB0006648157_GB
GB0006648157
Biotechnology & Medical Research
Sales 2023 | 89.54M 112M 153M | Sales 2024 * | 129M 162M 222M | Capitalization | 315M 394M 539M |
---|---|---|---|---|---|
Net income 2023 | -157M -197M -269M | Net income 2024 * | -36M -45.08M -61.63M | EV / Sales 2023 | 2.38 x |
Net cash position 2023 * | 49.23M 61.64M 84.27M | Net cash position 2024 * | 14.63M 18.32M 25.04M | EV / Sales 2024 * | 2.32 x |
P/E ratio 2023 |
-1.35
x | P/E ratio 2024 * |
-8.81
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 80.81% |
Latest transcript on Oxford BioMedica plc
Managers | Title | Age | Since |
---|---|---|---|
Frank Mathias
CEO | Chief Executive Officer | 62 | 23-03-26 |
Stuart Paynter
DFI | Director of Finance/CFO | 52 | 17-08-28 |
Chairman | 68 | 20-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leone Patterson
BRD | Director/Board Member | 61 | 23-04-30 |
Chairman | 68 | 20-06-23 | |
Stuart Henderson
BRD | Director/Board Member | 66 | 16-05-31 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |